AGF Investments Inc’s Maravai LifeSciences MRVI Stock Holding History

AGF Investments Inc’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-348	Closed	-$15K	–	618
2021 Q4	$15K	Buy	+348	New	+$14.1K	﹤0.01%	680

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AGF Investments Inc's MRVI Position: Q1 2022 in Review

AGF Investments Inc sold out of Maravai LifeSciences (MRVI) in Q1 2022, closing a stake of 348 shares — an estimated $15K sold.

AGF Investments Inc first reported a position in MRVI in Q4 2021 and held it in 1 quarter. The position peaked at $15K in Q4 2021. 235 funds tracked by Wall St. Rank hold MRVI as of Q1 2022.

AGF Investments Inc reported no remaining Maravai LifeSciences position as of Q1 2022 after selling out during the quarter.
AGF Investments Inc sold 348 Maravai LifeSciences shares in Q1 2022, an estimated $15K.
AGF Investments Inc first reported a position in Maravai LifeSciences in Q4 2021 and held it in 1 quarter.
AGF Investments Inc's Maravai LifeSciences position peaked at $15K in Q4 2021.
235 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.